Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 Vaccination in Cystic Fibrosis Patients
NCT01499914Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2009
- Primary completion
- Jan 2011
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of 2009 H1N1 influenza vaccine in influenza A H1N1 infection (H1N1), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Vaccine Efficacy at 1 year and Immunogenicity of A(H1N1)v influenza vaccine at Day 42. Started Nov 2009; status: completed.
02
Drugs
2009 H1N1 influenza vaccine
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT01499914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499914.